Women’s Health & Gynaecology
-
Studies question cervical cancer eradication claims
NHS officials produced new evidence of the success of HPV vaccination as a series of studies, published today, cast doubt on claims that cervical cancer could be eliminated. Read more
-
New breast cancer gene variants found
Hundreds of genetic risk factors for breast cancer have been identified in a large genome-wide association study, British researchers have announced. Read more
-
Anastrozole recommended for some post-menopausal women to stop cancer
Anastrozole should be the preventive drug recommended for post-menopausal women at increased risk of developing breast cancer, according to the findings of a new international study today. Read more
-
Blood test identifies rare breast cancer mutations
Rare mutations in advanced breast cancer can be identified through a simple blood test, in what clinicians have described as a “huge step”, it was announced last night. Read more
-
Gynaecologists call for women’s one-stop clinics and video consultations
Women are struggling to access basic healthcare services, according to a landmark report published today. Read more
-
High risk women revealed by neonatal abstinence syndrome
The mortality risk for mothers of babies born with neonatal abstinence syndrome is 11 times greater than normal, according to a new analysis. Read more
-
Range of health risks from asthma in pregnancy
Women who experience uncontrolled asthma attacks during pregnancy face further health risks, researchers warned today. Read more
-
Induce at 41 weeks, RCT finds
Inducing labour at 41 weeks of gestation is significantly safer than waiting another week, according to the findings of a major Swedish randomised study published today. Read more
-
Call for improved drug access for advanced breast cancer patients
A European conference has heard calls for improved access to drugs for patients with common forms of advanced breast cancer. Read more
-
Combination drug hope for some breast cancer patients
Some patients with HER2-positive breast cancer have responded well to the combination drug T-DM1, new research reveals today (15 November 2019). Read more